Johnson Alexander, Baeten John, Patel Ketan, Killian Molly, Sunny Sumsum, Suresh Amritha, Uma K, Birur Praveen, Kuriakose Moni, Kademani Deepak
Senior Product Development Engineer, Inter-Med, Inc, Racine, WI.
Director of Engineering/Research and Development, Inter-Med, Inc, Racine, WI.
J Oral Maxillofac Surg. 2019 Sep;77(9):1941-1951. doi: 10.1016/j.joms.2019.03.012. Epub 2019 Mar 26.
Currently available oral cancer screening adjuncts have not enhanced clinical screening methods because of high false positives and negatives, highlighting the need for a molecularly specific technique for accurate screening of suspicious oral lesions. The purpose of this study was to evaluate the in vivo screening accuracy of an oral lesion identification system that evaluates aberrant glycosylation patterns using a fluorescently labeled lectin (wheat germ agglutinin and fluorescein isothiocyanate [WGA-FITC]).
The authors designed and implemented a prospective cohort study at 3 institutions composed of patients with and without suspicious oral lesions. Oral cavities were screened by clinical examination and with the oral lesion identification system according to a stepwise procedure that included the topical application and fluorescence visualization of a fluorescent nuclear stain and WGA-FITC. Tissue samples were obtained from all enrolled patients for histopathological diagnosis and were used to calculate sensitivity and specificity metrics (primary outcome variable) irrespective of the oral lesion identification system result.
The sample was composed of 97 patients; 86 had 100 clinically suspicious lesions and 11 without such lesions were included as a control group. Use of the oral lesion identification system resulted in 100, 100, and 74% sensitivity for cancer, high-grade dysplasia, and low-grade dysplasia, respectively, and a specificity of 80%. Clinical diagnosis yielded similar sensitivity values of 84, 100, and 88% for cancer, high-grade dysplasia, and low-grade dysplasia, respectively, and a specificity of 76%. Use of the oral lesion identification system enhanced the visualization of lesion dimensionality and borders.
The results of this study suggest the oral lesion identification system was a beneficial adjunct to standard clinical examination, because the system provided sensitivity and specificity values similar to or greater than clinical diagnosis.
目前可用的口腔癌筛查辅助手段由于假阳性和假阴性率高,并未改善临床筛查方法,这凸显了需要一种分子特异性技术来准确筛查可疑口腔病变。本研究的目的是评估一种口腔病变识别系统在体内的筛查准确性,该系统使用荧光标记凝集素(麦胚凝集素和异硫氰酸荧光素[WGA-FITC])评估异常糖基化模式。
作者在3家机构设计并实施了一项前瞻性队列研究,研究对象为有和没有可疑口腔病变的患者。通过临床检查以及根据逐步程序使用口腔病变识别系统对口腔进行筛查,该程序包括局部应用荧光核染色剂和WGA-FITC并进行荧光可视化。从所有入组患者获取组织样本进行组织病理学诊断,并用于计算敏感性和特异性指标(主要结局变量),而不考虑口腔病变识别系统的结果。
样本包括97名患者;86名患者有100个临床可疑病变,11名无此类病变的患者作为对照组。使用口腔病变识别系统对癌症、高级别发育异常和低级别发育异常的敏感性分别为100%、100%和74%,特异性为80%。临床诊断对癌症、高级别发育异常和低级别发育异常的敏感性分别为84%、100%和88%,特异性为76%。使用口腔病变识别系统增强了病变维度和边界的可视化。
本研究结果表明,口腔病变识别系统是标准临床检查的有益辅助手段,因为该系统提供的敏感性和特异性值与临床诊断相似或更高。